Benzodiazepine use among adults residing in the urban settlements of Karachi, Pakistan: A cross sectional study by Iqbal, Saleem P et al.
RESEARCH Open Access
Benzodiazepine use among adults residing in the
urban settlements of Karachi, Pakistan: A cross
sectional study
Saleem P Iqbal
1*, Syed Ahmer
2, Salima Farooq
3, Yasmin Parpio
3, Ambreen Tharani
3, Rashid AM Khan
2 and
Mohammad Zaman
2
Abstract
Background: There are hardly any studies carried out in Pakistan on the usage of benzodiazepines at the level of
community. This research was aimed to determine the frequency of benzodiazepine use, along with its
associations with socio-demographic and clinical characteristics among community dwelling adults, residing in two
urban settlements of Karachi, Pakistan.
Methods: We performed a cross sectional study from August 2008 to December 2009, in 2 areas of Karachi,
namely Garden and Sultanabad. We followed the systematic sampling strategy to randomly select the households,
with an adult of either sex and of age 18 years or more. Data collection was carried out through interview, using a
pre-tested questionnaire, with items on socio-demographic position, medical history and benzodiazepine use.
Student’s t-test and c
2 test was employed to determine the associations between socio-demographic and clinical
characteristics, and their relationship with benzodiazepine use was determined using applied logistic regression.
Results: The overall percentage of benzodiazepine consumption was estimated to be 14%. There were significantly
more benzodiazepine users in the peri-urban Sultanabad community to the urban community of Garden (p-value
= 0.001). The mean age (± SD) for users was 51.3 (± 15.6) years compared to 37.1 (± 14.4) years among non-users.
Bromazepam was the most widely used benzodiazepine (29%); followed by diazepam, with a median duration on
primary use being 144 weeks (IQR = 48-240). The adjusted logistic regression model revealed that increasing age,
location, female sex, unemployment and psychiatric consultation were associated with increased likelihood of
benzodiazepine use.
Conclusion: We believe the unregulated over-the-counter sales of benzodiazepines and social conditions might be
playing a role in this high consumption of benzodiazepines in the community.
Background
After the discovery of chlordiazepoxide in 1957, benzo-
diazepines are among the most widely used drugs in the
general population [1-6]. These were generally pre-
scribed to combat anxiety and insomnia but over time
these are now being used for a wide array of psychiatric
and non-psychiatric illnesses, in view of their sedative,
anti-convulsant and muscle relaxing properties [1,7-9].
Despite their therapeutic uses, tendency remains for
benzodiazepine abuse among the general population.
Several adverse reactions have been reported in studies
which include cognitive decline, motor disturbances,
unwanted sedation and reduced coordination [10,11]. In
addition, benzodiazepines pose a risk of dependence
which may become as high as 45% after 6 months of
continuous use [12,13]. In view of this, benzodiazepine
sale and usage have been regulated in many developed
countries [14]. However, this is not commonly practiced
in most developing countries, including Pakistan, where
practically these can be purchased over-the-counter,
with considerable ease [9,15,16].
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pine use, types of population and settings, and periods
of observation, estimates reveal that prevalence of ben-
zodiazepine consumption may range from 2% to 17%
[17,18]. A recent summary from USA reports a 12-
month prevalence of use of benzodiazepines (as tranqui-
lizers) as 8.6% [19]. In a local study, the percent use of
benzodiazepines among in-patients in a tertiary care
hospital in Pakistan is reported to be 21.2% [16]. In
another recent study on outpatients in 2 tertiary care
hospitals, use of benzodiazepines is reported to be
around 45% [20].
There are hardly any studies in this region to estimate
the frequency of benzodiazepine use at the level of com-
munity. Most studies in the Western countries have
been conducted on elderly populations (more than 65
years) where the prevalence estimates have been found
to be 9.9% in USA, 20% in Canada and 31.9% in France
[21-23]. From a study in Brazil, a 22% frequency of ben-
zodiazepine use has been reported among elderly per-
sons living in the community [24,25]. Few studies have
been carried out in the general population even in the
developed countries. For example studies from Boston,
France and Lebanon benzodiazepine usage has been
reported to be 7.3%, 7.5% and 9.9%, respectively [26-28].
In another study a prevalence estimate of 9.2% benzo-
diazepine usage was reported from a combined popula-
tion of 6 European countries [29]. Such estimates are
not available for a developing country like Pakistan,
where we might expect these to be much higher owing
to easy accessibility of these drugs, without a
prescription.
Risk factors, common to benzodiazepine use are
increasing age and female gender, and have been
reported in most studies, regardless of the population
[16,20,22,24,25,27,28,30]. Other reported associations
are cigarette smoking, marital status, education and
occupation [16,27,28]. The objective of the present
study was to estimate the frequency of benzodiazepine
use among 2 populations in Karachi, Pakistan, and to
determine its associations with related socio-demo-
graphic and clinical characteristics which are unique to
these populations.
Methods
Study Design and settings
A cross sectional study was conducted from August
2008 to December 2009. Two sites from the metropoli-
tan city of Karachi, Pakistan were selected for this
research, namely Sultanabad and Garden, as community
health services were provided to these areas by the Aga
Khan University. Moreover, there were differences in
the socio-economic conditions in these 2 areas.
Sultanabad is a relatively low income squatter settle-
ment situated in the district East of Karachi. Mainly
inhabited by the Pashtoon and Punjabi migrants from
northern Pakistan, it has a population of more than
53000 people. Garden is one of the neighborhoods adja-
cent to the Central district of Karachi. Estimated popu-
lation is more than 65000 and majority of the people
belong to a relatively affluent group. Due to these rea-
sons, these places were well suited to have a compara-
tive assessment of benzodiazepine use among the
community people.
Sampling strategy
We used a systematic random sampling approach to
randomly select a representative sample from each of
the study sites. About 4000 households from Sultanabad
and about 5000 households from Garden were available
for this study. Employing the strategy, every 10
th house-
hold was approached for the interview starting from a
random pick using random number tables, from the
first 10 households. Our inclusion criteria were to select
an adult of age 18 years and above of either sex. If the
subject from a household was found unwilling to partici-
pate in the study, the adjacent house was approached.
Data Collection
Data were collected using a specially designed question-
naire, similar to the questionnaire used in a previously
published study (20). The participation by the subjects
was voluntary. At first they were inquired about their
demographic and socioeconomic position such as age,
gender, marital status, ethnicity, education and occupa-
tion. Following that, questions related to any medical
and psychiatric ailments, any consultations and if any
medications used were asked. If benzodiazepines were
found in use, the subjects were asked whether it was self
medication or prescribed. In addition, the duration, fre-
quency, dose and route of administration were noted.
Equivalent doses were later calculated using the Mauds-
ley Prescribing Guidelines [31].
Statistical Analysis
Analyses were performed using the Statistical Package
for Social Sciences for Windows version 17 (SPSS Inc.,
Chicago, IL., USA). Frequencies were calculated for all
characteristics and expressed in either means (± SD) or
medians (IQR) for quantitative variables and percentages
for categorical characteristics. Chi-square (c
2)o fi n d e -
pendence was used to determine significant associations
between categorical variables, whereas t-test was
employed to assess the differences among quantitative
characteristics. Applied logistic regression was used to
determine the factors predicting the likelihood of
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sidered significant.
Ethical approval
Informed consent was obtained before interviewing the
subjects for the study. They were told that their partici-
pation was voluntary and they were at liberty to refuse
if they wished so. The study was approved by the Ethics
Review Committee (ERC) of the Aga Khan University.
Results
Tables 1 and 2 summarize the socio-demographic and
clinical characteristics with respect to benzodiazepine
u s a g ei nt h eo v e r a l ls a m p l ea n da tt h e2s i t e s ,r e s p e c -
tively. A total of 749 subjects were recruited, out of
which 102 (14%) were currently using benzodiaze-
pines. Benzodiazepine users was older compared to
the non-users (mean age 51.3 ± 15.6 years vs. 37.1 ±
14.4 years; t = -9.1; df = 746; p-value < 0.001). Signifi-
cantly more females compared to males were using
benzodiazepines (17% vs. 9%; Wald c
2 =8 . 1 ;d f=1 ;
p-value = 0.004).
The mean ages between male and female benzodiaze-
pine users were not significantly different (mean age
51.6 ± 14.2 years vs. 50.8 ± 16.2 years; t = 0.24; df = 93;
p-value = 0.81). Majority of the people in the sample
were married (67%), and 18% of them were consuming
benzodiazepines. Benzodiazepine use was highest (43%)
in the category of uneducated persons. In terms of fre-
quency of benzodiazepine use in the 2 communities,
there is significantly greater proportion of users in the
peri-urban area of Sultanabad, compared to Garden
(Table 1). Moreover in this area, the people were rela-
tively less educated compared to the people in Garden
area (Table 2).
In these 2 samples, 16% had a history for coronary
artery disease (CAD), while diabetes mellitus was
reported to be 7%. A total of 28 (4%) subjects had
reported to be suffering from depression, from which
21 (75%) were using benzodiazepines. Among the
recruited subjects, 36 reported to have seen a psychia-
trist before the interview. From those, 22 were using
benzodiazepines.
Data on users
The most used benzodiazepine was bromazepam (29%),
followed by diazepam (26%), alprazolam (24%) and lora-
zepam (24%). The median duration of primary use was
144 weeks (IQR = 48-240)). About 67% reported to have
been using benzodiazepines continuously; 46% of them
reported to have been using these daily, and 21% were
using it on a weekly basis. We estimated the median
diazepam equivalent dose to be 10 mg (IQR = 5-25). A
small proportion had been using on the advice of a
Table 1 Characteristics of the study population with respect to benzodiazepine use (n = 749)
Characteristics Total Benzodiazepine users Wald c
2 df P-value OR (95% CI)
Age (means ± SD) 38.96 ± 15.33 51.30 ± 15.58 62.7 1 0.001 1.06 (1.04-1.07)
Location Garden, n (%) 383 33 (9) 1
Sultanabad, n (%) 366 69 (19) 15.9 1 0.001 2.46 (1.58-3.84)
Gender Male, n (%) 349 33 (9) 1
Female, n (%) 399 67 (17) 8.4 1 0.004 1.93 (1.24-3.01)
Marital Status Unmarried, n (%) 249 12 (5) 1
Married, n (%) 500 88 (18) 20.5 1 0.001 4.22 (2.26-7.87)
Education Post-graduation, n (%) 71 5 (7) 1
Graduation, n (%) 213 17 (8) 19.5 1 0.001 1.15 (0.41-3.22)
Intermediate, n (%) 171 13 (8) 6.3 1 0.01 1.09 (0.37-3.17)
Secondary, n (%) 176 21 (12) 1.3 1 0.26 1.79 (0.65-4.94)
Primary, n (%) 35 9 (26) 0.02 1 0.9 4.57 (1.40-14.93)
None, n (%) 72 31 (43) 0.07 1 0.8 9.98 (3.59-27.73)
Occupation Student, n (%) 98 4 (4) 1
Salaried workers, n (%) 128 17 (13) 5 1 0.03 3.60 (1.17-11.07)
Housewife, n (%) 195 44 (23) 12.8 1 0.001 6.85 (2.38-19.68)
Retired, n (%) 31 9 (29) 12.3 1 0.001 9.61 (2.71-34.10)
Labor, n (%) 197 14 (7) 1 1 0.313 1.80 (0.58-5.61)
Business, n (%) 81 6 (7) 0.9 1 0.342 1.88 (0.52-6.91)
Unemployed, n (%) 10 5 (50) 15.1 1 0.001 23.50 (4.78-115.59)
Psychiatric consult No, n (%) 703 75 (11) 1
Yes, n (%) 36 22 (61) 50.4 1 0.001 13.16 (6.46-26.81)
SD = Standard deviation; df = degrees of freedom; OR = Odds ratio; CI = Confidence interval
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upon either the prescription of local practitioners (40%)
or self (24%). Only 22% of the users were taking these
for genuine complaints, especially depression, while
most were using for minor complaints such as insomnia
(21%) and anxiety (8%).
Using applied logistic regression, crude estimates for
odds ratios for educational categories revealed that the
odds of benzodiazepine use were more among less edu-
cated subjects (Table 1). In the category of occupation,
crude estimates revealed the likelihood of greater use
among the unemployed, retired, housewives and salaried
worker categories (Table 1). In the adjusted model,
increasing age, location of residence, female sex, unem-
ployment and psychiatric consult were associated with
increase in odds of benzodiazepine use in the commu-
nity (Table 3).
Discussion
The purpose of this study was to estimate the frequency
of benzodiazepine use among the 2 local communities
in Karachi, Pakistan. To the best of our knowledge, no
study of this kind has been conducted in this region.
Table 2 Characteristics of the study population with respect to location
Characteristics Sultanabad (n = 366) Garden (n = 383) Test df P-value
Age (means ± SD) 38.09 ± 15.3 39.81 ± 15.3 t = -1.53 743 0.13
Gender c
2 = 3.2 1 0.08
Male, n (%) 157 (43) 190 (50)
Female, n (%) 206 (57) 192 (50)
Marital Status c
2 = 4.4 1 0.04
Unmarried, n (%) 134 (38) 113 (30)
Married, n (%) 230 (62) 269 (70)
Education c
2 = 31.9 5 0.01
Post-graduation, n (%) 32 (9) 38 (10)
Graduation, n (%) 114 (32) 98 (26)
Intermediate, n (%) 67 (19) 104 (27)
Secondary, n (%) 70 (20) 106 (28)
Primary, n (%) 28 (8) 7 (2)
None, n (%) 43 (12) 28 (7)
Occupation c
2 = 34.5 6 0.01
Student, n (%) 50 (14) 47 (12)
Salaried workers, n (%) 90 (25) 38 (10)
Housewife, n (%) 78 (22) 117 (31)
Retired, n (%) 12 (3) 19 (5)
Labor, n (%) 93 (26) 104 (27)
Business, n (%) 33 (9) 48 (13)
Unemployed, n (%) 3 (1) 6 (2)
Psychiatric consult c
2 = 0.82 1 0.36
No, n (%) 346 (96) 354 (94)
Yes, n (%) 15 (4) 21 (6)
SD = standard deviation
df = degrees of freedom
Table 3 Adjusted odds ratios (with 95% CI) computed
using multiple logistic regression
Characteristics Wald
c
2
df P-
value
Adjusted OR
(95% CI)
Age 29.9 1 0.001 1.06 (1.04-1.09)
Location Garden 1
Sultanabad 25.3 1 0.001 4.49 (2.50-8.10)
Gender Male 1
Female 4.0 1 0.04 2.20 (1.02-4.75)
Marital status Unmarried 1
Married 3.0 1 0.08 2.39 (0.89-6.40)
Occupation Student 1
Professional 0.03 1 0.86 0.89 (0.20-4.08)
Housewife 0.36 1 0.55 0.61 (0.12-3.18)
Retired 0.25 1 0.62 1.66 (0.24-11.67)
Labor 0.13 1 0.71 0.68 (0.14-3.36)
Business 0.93 1 0.33 0.39 (0.06-2.78)
Unemployed 4.9 1 0.03 14.50 (1.38-151.87)
Psychiatric
consult
No 1
Yes 40.8 1 0.001 18.9 (7.68-46.65)
df = degrees of freedom; OR = Odds ratio; CI = Confidence interval
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died sample was 14%; higher than that reported in Bos-
ton, France and Lebanon [26-28]. One reason for this
high estimate could be the unregulated availability of
benzodiazepines in the local market. Additionally, in
presence of co-morbidities such as hypertension, general
practitioners do prescribe benzodiazepines for better
control and relief. Our study showed that about 40% of
cases with co-morbidities had been using benzodiaze-
pines on the advice of general practitioners. The
reported high estimates point to the need to caution
both doctors and patients on the associated risk of
dependence, and to regulate the accessibility of benzo-
diazepines in this country.
Benzodiazepine users in our sample were mostly
elderly females. This finding is quite consistent with the
findings by other researchers [22,24,27-29,32-36]. Older
p e o p l ea r em o r el i k e l yt ob eu s i n gb e n z o d i a z e p i n e sf o r
relieving insomnia and anxiety related to isolation,
depression and medical ailments [37,38]. Reports also
suggest that anxiety occurs more in females compared
to males [36,39]. Moreover, as females tend to live
longer than males, the psychological problems are more
likely to be encountered by them [40]. Another impor-
tant fact is that females, in general, are more cooperative
in explaining their health problems and thus are rela-
tively more compliant towards the prescribed medica-
tions [40,41].
Bromazepam was found to be the most used benzo-
diazepine in the study settings. Similar results have also
been reported in community based studies in Brazil
[24,42]. The second most commonly used benzodiaze-
pine was diazepam. The median duration of primary use
in our study was 144 weeks, whereas the recommended
duration by clinicians/psychiatrists should not be more
than 4 weeks [43]. According to literature, caution
should be exercised while prescribing benzodiazepines;
as in case of those with shorter half lives and high
potency, there is a tendency for therapeutic dose depen-
dence; while those with longer half lives are usually
associated with impaired cognition and prolonged seda-
tion, as the drug may get accumulated in the body of
the individual [44-47]. In Pakistan, the situation is quite
serious due to the easier access of these drugs over-the-
counter. This may pose a risk to the general population.
In this research, we found the use of benzodiazepines
more among the less educated class of subjects. Other
researchers have also shown the maximum use of ben-
zodiazepines among the less educated individuals
[32,36,48]. Awareness regarding the risks associated with
benzodiazepine use among the educated individuals
could be a plausible reason for restricted use of these
drugs. In our study, this was not significant in the multi-
variable model, perhaps due to stratification of the
educational categories. The adjusted regression model
showed that the unemployed persons were more
inclined to use benzodiazepines. Similar findings have
been also reported by other investigators, such as Lag-
naoui et al. who have indicated higher rates of benzodia-
zepine use among jobless individuals [27].
Our results should be seen within the context of cer-
tain limitations of this research. This study being the
first of its kind in this country, describes the “current”
status of benzodiazepine use. Another limitation could
be fewer subjects in the occupational category for
unemployment (1.3%); which, though significant, we
believe could be “under-reporting.” In low income com-
munities a reasonable proportion of population might
have been working for just 1-2 days in a week and con-
sidering themselves as employed. We presented the
results for 2 different communities in Karachi and these
2 sites would not be representative of the whole city of
18 million people. Nonetheless, we believe the results to
be fairly representative of the concerned populations
owing to the systematic random sampling employed in
the research and a reasonable sample size. The findings
we present are consistent with what has been reported
by other researchers on Western populations. More sur-
veys at multiple communities would provide a deeper
insight into the prolonged use of benzodiazepines and
various factors governing its usage, in Pakistan. This
would provide the necessary sensitization of the medical
community and measures to be taken to effectively con-
trol benzodiazepine use in the developing world.
Conclusion
The proportion of benzodiazepine use in the 2 commu-
nities of Karachi, Pakistan is relatively higher than that
reported in the developed countries. It is a matter of
concern in view of the associated adverse events and the
prevalent physical and psychological conditions in devel-
oping countries. Further research at the national level
would be imperative to provide a deeper insight into the
problem of prolonged benzodiazepine use especially
without a proper consult of a psychiatrist (only 4.7% in
the study sample had been seen by a psychiatrist and
among the benzodiazepine users nearly 40% had been
using it without a psychiatric consult) and its associated
mental health issues. Sensitization of the medical com-
munity and the masses to this growing problem of ben-
zodiazepine use and associated risks is necessary to
control it in the developing societies.
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